Skip to main content
TipRanks
Go Ultimate75% OFF

IGC Pharma (IGC) Q4 2022 Earnings Report

1,058 Followers

IGC Q4 2022 EPS Results

Actual EPS
-$0.13
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-$0.07

IGC Q4 2022 Revenue Results

Actual Revenue
$122.00K
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+50.62%

Earnings Announcement Details

Quarter
Q4 2022
Date
06/23/2022
Time
Before Open
Conference Call
Thursday, June 23, 2022
IGC Upcoming Earnings

IGC Pharma's next earnings date is estimated for February 5, 2027, based on past reporting schedules.

Q4 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

IGC Earnings History

IGC earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 05, 20272027 (Q3)-0.02--0.01――
Nov 09, 20262027 (Q2)-0.02-0.02-0.020.00% (+0.00)
Jun 15, 20262026 (Q4)―-0.02-0.020.00% (+0.00)
Mar 19, 20262026 (Q3)-0.02-0.01-0.0250.00% (+0.01)
Nov 17, 20252026 (Q2)-0.02-0.02-0.020.00% (+0.00)
Aug 19, 20252026 (Q1)―--0.03―
Jun 30, 20252025 (Q4)-0.02-0.02-0.0333.33% (+0.01)
Feb 18, 20252025 (Q3)-0.03-0.02-0.0977.78% (+0.07)
Nov 14, 20242025 (Q2)-0.03-0.02-0.0560.00% (+0.03)
Aug 09, 20242025 (Q1)-0.03-0.03-0.0423.08% (+0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed